Over a year and a half into the COVID-19 pandemic and the establishment of the Access to COVID-19 Tools Accelerator (ACT-A), questions about future pandemic preparedness responses are dominating global public health discussions. The ACT-A recently undertook a review for the stated purpose of potentially extending its mandate until the end of 2022, primarily on
Statement on Global COVID-19 Summit from ACT-A Civil Society Representatives Following the Global COVID-19 Summit: Ending the Pandemic and Building Back Better on 22 September, the civil society representatives to ACT-A published a statement, recognising that whilst the the Summit aimed to catalyse and welcome momentum to progress the pandemic response, its targets fall far
The Communities and Civil Society ACT-A Platform is seeking interested individuals for the following distinct roles:● Project Lead (0.8 FTE)● Platform Coordinator (0.8 FTE)● Pillar Focal Points (0.4 FTE x 4 positions – with the possibility of Focal Points having 2 roles) Vaccines/COVAX, Diagnostics, Therapeutics and Health Systems Connector Deadlines:Applications are due by June 23rd
Communities and Civil Society representatives in the ACT-A Diagnostics Pillar wrote to the Head of the WHO and others about the inequitable expansion of antigen rapid diagnostic tests (Ag RDT’s) use across the world with many global north countries regularly testing in workplaces, schools and even self-testing at home while the current WHO guidelines in
The Platform for Civil Society and Community Representatives to ACT-A and the Gavi CSO Steering Committee are currently inviting applications for representatives to the COVAX Manufacturing Taskforce. The Civil Society & Communities Representatives to the COVAX Manufacturing Taskforce will advocate the viewpoints and needs of NGOs and Communities within the taskforce, working closely with the
The Covid-19 Technology Access Pool (C-TAP) was recently relaunched and community and civil society representatives in ACT-A released a statement welcoming the re-launch and urging immediate support for C-TAP. Read the full statement which includes key asks of manufacturers, donors and governments to support, fund and operationalise C-TAP urgently here. The full statement is available
The ACT-A Facilitation Council held its 6th meeting on May 12th 2021. Dr Fifa Rahman and Peter Ngola O’witi spoke in their capacity as Communities and Civil Society representatives during the meeting; Dr Rahman on barriers and strategies for increasing uptake and use of COVID-19 tools at country level and Peter O’witi on COVAX manufacturing
Working with community and civil society colleagues who focus on oxygen access, ACT-A Facilitation Council Representatives Dr. Fifa Rahman and Peter O’Witi wrote to Boris Johnson, Prime Minister of the UK – as host of this years G7 – to urge action to address current oxygen crises and investment and action to mitigate potential future
As the COVAX investment opportunity is launched on Thursday 15 April, the civil society representatives to COVAX have published a statement on the need for a fully funded COVAX to ensure fair and equitable distribution to lifesaving COVID-19 vaccines globally. A copy of the statement can be found here.
During February and March, the Platform of Community and Civil Society Representatives in ACT-A co-leads (WACI Health, StopAIDS and GFAN) led an open and transparent process to identify and select permanent community and civil society representatives to the Health Systems Connector of the ACT-A. The Health System Connector (HSC) – also referred to as the
© Copyright 2024 Platform for ACT-A Civil Society and Community Representatives. Privacy Policy